Loading company…
Moat Biotechnology develops intranasal and oral vaccines using its SC-AdVax platform.
Founded in 2022, Moat Biotechnology is based in Oklahoma, US, and develops vaccines for mucosal and systemic immunity. Its SC-AdVax platform, licensed from the Mayo Clinic, is being used to develop vaccines for viruses and infectious diseases. In June 2023, the company raised USD 6.5 million led by Cortado Ventures, with Boyd Street Ventures participating, to expand a Phase 1 COVID-19 trial and develop additional vaccines.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in